This article describes a combined functional and urinary biomarker-based approach to predict renal replacement therapy requirements in patients with sepsis-associated acute kidney injury.
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Research Article
This article describes a combined functional and urinary biomarker-based approach to predict renal replacement therapy requirements in patients with sepsis-associated acute kidney injury.
This study aimed to investigate the predictive value of a model combining the furosemide stress test (FST) with urinary tissue inhibitor of metalloproteinase-2 (TIMP-2) and insulin-like growth factor-binding protein 7 (IGFBP-7) for predicting renal replacement therapy (RRT) initiation within 7 days in patients with sepsis-associated acute kidney injury (SA-AKI). A total of 63 patients with SA-AKI admitted to the intensive care units (ICU) of Zhongwei People’s Hospital and the Affiliated Hospital of Ningxia Medical University between January 2025 and November 2025 were enrolled in this study. According to whether RRT was initiated within 7 days, patients were divided into an RRT group (n = 20) and a non-RRT group (n = 43). Clinical characteristics, laboratory parameters, and urinary biomarkers were collected. Urinary TIMP-2 and IGFBP-7 levels were measured using enzyme-linked immunosorbent assay, and the predictive performance of FST combined with urinary [TIMP-2] * [IGFBP-7] was evaluated using multivariate logistic regression and receiver operating characteristic (ROC) curve analysis. The results showed that 20 patients (31.7%) required RRT during follow-up, while 43 patients (68.3%) did not. Compared with the non-RRT group, patients in the RRT group exhibited more severe renal dysfunction and higher incidence of adverse kidney events. ROC analysis demonstrated that the area under the curve (AUC) for FST, baseline TIMP-2*IGFBP-7, TIMP-2*IGFBP-7 measured 2 h after FST, and the combined model were 0.878, 0.820, 0.845, and 0.966, respectively. Multivariate logistic regression further confirmed that the combined FST and urinary TIMP-2*IGFBP-7 indicator was an independent predictor of RRT requirement. These findings suggest that the combined FST and urinary TIMP-2*IGFBP-7 model may be useful for early risk stratification of SA-AKI patients at high risk of requiring RRT.
Sepsis is a critical clinical syndrome commonly encountered in the intensive care unit (ICU), characterized by high morbidity and mortality. The systemic inflammatory response triggered by sepsis can lead to multiple organ dysfunction, among which sepsis-associated acute kidney injury (SA-AKI) is one of the most common and severe complications1,2,3. Previous studies have reported that approximately 40%–50% of patients with sepsis develop SA-AKI, which is associated with significantly increased mortality4,5,....
Access restricted. Please log in or start a trial to view this content.
Patient enrollment and ethical approval
This study was designed as a prospective two-center cohort study. The study population consisted of patients with sepsis-associated acute kidney injury (SA-AKI) who were admitted to the intensive care units (ICU) of Zhongwei People’s Hospital and the General Hospital of Ningxia Medical University between January 2025 and November 2025. The study protocol was approved by the Ethics Committees of the General Hospital of Ningxia Medical University (Approval No. KYLL-2025-1232) and Zhongwei People’s Hospital, Ningxia, China (Approval No. NXZWSRMYYLL-202445). All procedures were conducted in accorda....
Access restricted. Please log in or start a trial to view this content.
Patient enrollment and baseline characteristics
A total of 100 patients were initially screened in this study. After excluding 30 patients without sepsis, 5 patients with missing data, and 2 patients who withdrew from the study, a total of 63 patients with confirmed sepsis-associated acute kidney injury (SA-AKI) were finally included in the analysis. Among them, 42 were male, and 21 were female, with a mean age of 67.25 ± 14.5 years. Based on whether renal replacement therapy (RRT) was initiated with.......
Access restricted. Please log in or start a trial to view this content.
Sepsis-associated acute kidney injury (SA-AKI) is a common and severe complication in patients admitted to the intensive care unit (ICU). Its pathophysiological mechanisms are complex and involve multiple processes, including inflammatory responses, microcirculatory dysfunction, and oxidative stress18. Timely and appropriate initiation of renal replacement therapy (continuous renal replacement therapy, CRRT) is critical for improving the prognosis of patients with SA-AKI. However, the optimal timi.......
Access restricted. Please log in or start a trial to view this content.
The authors have no conflicts of interest to disclose.
Author Contributions:
Shujuan Ning and Xiaojun Yang designed the study. Shujuan Ning, Jingyan Chen, Jinlan Ma, Shenglin Su, and Bo Li enrolled patients and collected clinical data and samples. Shujuan Ning analyzed the data and drafted the manuscript. Xiaojun Yang revised the manuscript. All authors approved the final manuscript.
This work was supported by the Key Research and Development Program of Social Development (Health) of Zhongwei City (2024shfz007).
....Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| Automated Biochemical Analyzer | Mindray Bio-Medical Electronics Co., Ltd., Shenzhen, China | BS-800 | |
| Biosafety Cabinet | Airtech (Suzhou) Co., Ltd., Suzhou, China | BSC-1300IIA2 | |
| Blood Gas Analyzer | Edan Instruments, Inc., Shenzhen, China | i15 | |
| Centrifuge (Low-speed refrigerated centrifuge) | Xiangyi Centrifuge Instrument Co., Ltd., Changsha, China | H1850 | |
| ELISA Kit for IGFBP-7 | Elabscience Biotechnology Co., Ltd., Wuhan, China | E-EL-H5567 | |
| ELISA Kit for TIMP-2 | Elabscience Biotechnology Co., Ltd., Wuhan, China | E-EL-H0003 | |
| ELISA Microplate Reader | Rayto Life and Analytical Sciences Co., Ltd., Shenzhen, China | RT-6100 | |
| ELISA Plate Washer | Rayto Life and Analytical Sciences Co., Ltd., Shenzhen, China | RT-2600C | |
| Furosemide | Not specified in submission files | Not specified in submission files | Administered intravenously at 1.0–1.5 mg/kg for FST |
| Infusion Pump | Mindray Bio-Medical Electronics Co., Ltd., Shenzhen, China | BeneFusion SP5 | |
| Micropipette | Dragon Laboratory Instruments Co., Ltd., Shanghai, China | TopPette | |
| Microplate (96-well ELISA plate) | Elabscience Biotechnology Co., Ltd., Wuhan, China | E-EL-Plate96 | |
| Multiparameter Patient Monitor | Mindray Bio-Medical Electronics Co., Ltd., Shenzhen, China | BeneVision N12 | |
| Pipette Tips (200 μL) | Dragon Laboratory Instruments Co., Ltd., Shanghai, China | T-200 | |
| R software | Not specified in submission files | Not specified in submission files | Used for statistical analyses |
| Refrigerated Storage (4 °C Medical Refrigerator) | Haier Biomedical Co., Ltd., Qingdao, China | HYC-290 | |
| Sterile Sample Tubes | Kangjian Medical Supplies Co., Ltd., Jiangsu, China | KJ-ST02 | |
| Ultra-Low Temperature Freezer (-80 °C) | Haier Biomedical Co., Ltd., Qingdao, China | DW-86L388 | |
| Urine Collection Tubes | Kangjian Medical Supplies Co., Ltd., Jiangsu, China | KJ-UT01 |